Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02980887 · ClinicalTrials.gov registry record
Pulmonary Vascular Disease Phenomics Program PVDOMICS
A clinical trial of Pulmonary Arterial Hypertension, sponsored by The Cleveland Clinic.
- Active
- Registry status
- 1,195
- Enrollment target
- 7
- Study locations
NCT02980887: Active study of Pulmonary Arterial Hypertension, sponsored by The Cleveland Clinic.
NCT02980887 is a study of Pulmonary Arterial Hypertension that is active but no longer recruiting, run by The Cleveland Clinic. The registered enrollment target is 1,195 participants, above the 443-participant average among 63 other Pulmonary Arterial Hypertension trials with a reported enrollment target (170% higher). The trial reports 7 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02980887, a study of Pulmonary Arterial Hypertension, is active but no longer recruiting, sponsored by The Cleveland Clinic.
- ACTIVE NOT RECRUITING
- Registry status
- 1,195 participants
- Enrollment target
- 7
- Study locations
Study Summary
It is recognized that patients with various forms of heart and lung disease exhibit varying degrees of pulmonary hypertension, pulmonary vascular remodeling, and right ventricular dysfunction. The genetic, molecular, and cellular processes driving these phenomena are not well understood. Rapid advances in high throughput omic methodology, combined with powerful bioinformatics and network biology capability, have created the opportunity to conduct studies that broadly search for homologies and differences across the spectrum of disease states associated with pulmonary hypertension, and determinants of the spectrum of right ventricular compensation that accompanies these conditions
Primary Outcome
OMICs analyses will be used to assign new class of PVD
Conditions Studied
Interventions
- OTHER No Intervention
Study Locations (7)
New York
- Weill Cornell Medicine - New York
- New York Medical College - Valhalla
Arizona
- University of Arizona Health Sciences Center - Tucson
Maryland
- Johns Hopkins University School of Medicine - Baltimore
Massachusetts
- Brigham and Women's Hospital - Boston
Minnesota
- Mayo Clinic - Rochester
Tennessee
- Vanderbilt University Medical Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,195 participants |
| Start Date | 2016-11 |
| Est. Completion | 2029-12-31 |
What the registry record for NCT02980887 still lists
NCT02980887 is an observational study that tracks outcomes without assigning an intervention. Its 1,195 participants enrollment target places it among the larger protocols in the corpus, above the 443-participant average among 63 other Pulmonary Arterial Hypertension trials with a reported enrollment target (170% higher).
The record links to 1 condition, with Pulmonary Arterial Hypertension appearing as the primary indexed condition, and to 1 intervention - of which No Intervention is the first listed.
NCT02980887 lists 7 locations in 6 states (New York, Arizona, Maryland).
Frequently Asked Questions
What is clinical trial NCT02980887 about?
NCT02980887 is a clinical study titled "Pulmonary Vascular Disease Phenomics Program PVDOMICS". It is recognized that patients with various forms of heart and lung disease exhibit varying degrees of pulmonary hypertension, pulmonary vascular remodeling, and right ventricular dysfunction. The genetic, molecular, and cellular processes driving these phenomena are not well understood. Rapid advan...
What is the current status of trial NCT02980887?
This trial is currently active not recruiting. The enrollment target is 1,195 participants. The study started on 2016-11. Estimated completion is 2029-12-31.
What conditions does trial NCT02980887 study?
This clinical trial studies the following conditions: Pulmonary Arterial Hypertension.
What interventions are being tested in trial NCT02980887?
The interventions under investigation include: No Intervention (OTHER).
Who is sponsoring clinical trial NCT02980887?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02980887 being conducted?
This trial has 7 study locations across Arizona, Maryland, Massachusetts, Minnesota, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pulmonary Arterial Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02980887's enrollment target sits among peer trials
1,195 6th of 63 higher than 58 of 63 other Pulmonary Arterial Hypertension trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pulmonary Arterial Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System
RECRUITING · NA
-
The MObile Health InterVEntion in Pulmonary Arterial Hypertension (MOVE PAH) Study
RECRUITING · NA
-
Trial to Evaluate Parenteral Treprostinil and Riociguat on Right Ventriculo-vascular Coupling and Morphology in Those With Advanced PAH
RECRUITING · Phase 3
-
A Placebo-controlled, Randomized Clinical Trial to Assess the Safety, Feasibility, and Pharmacokinetics of Microbiota Transplant Therapy With Antibiotic Preconditioning and Fiber Supplementation in Patients With Pulmonary Arterial Hypertension
RECRUITING · Phase 1
-
129 Xenon MRI as a Biomarker for Diagnosis and Response to Therapy in Pulmonary Arterial Hypertension (PAH)
RECRUITING · Phase 2
-
Pulmonary Hypertension SOLAR
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07177339 · 1,196 participants · Phase 3
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
- NCT00001987 · 1,200 participants
Genetic Studies of Insulin and Diabetes
- NCT00477100 · 1,200 participants
Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer
- NCT01209000 · 1,200 participants
Nephrotic Syndrome Study Network
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia